Reglagene Nails RESI Partnering with 25 Investor Meetings

In April, Reglagene participated in their most successful partnering event to date. Reglagene's CEO Richard Austin had 25 investor partnering meetings in a two-day period! Part of this success came from updated pitch decks, executive summaries, and a new tagline, while other successes came from how Reglagene engages with investors throughout the entire process.

Karen Deyo, the Senior Investor Research Analyst at Life Science Nation, interviewed Richard about his experience and how he pulled off such an incredible two-day event.

Click here to read the full interview.

Previous
Previous

New Research Validates QMST in the Development of Epigenetic Medicines

Next
Next

NINDS Awards Reglagene $400,000 to Investigate a New Treatment for Glioblastoma Multiforme